{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:22:10Z","timestamp":1781767330605,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Uni-Pharma SA, Athens, Greece"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12602-018-9401-3","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T08:35:42Z","timestamp":1520238942000},"page":"627-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth"],"prefix":"10.1007","volume":"11","author":[{"given":"Konstantinos","family":"Leventogiannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevas","family":"Gkolfakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Spithakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Tsatali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Pistiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Sioulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-3911","authenticated-orcid":false,"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Triantafyllou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"9401_CR1","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1365-2036.2005.02690.x","volume":"22","author":"A Lupascu","year":"2005","unstructured":"Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, Flore R, Tondi P, Pola P, Gasbarrini G, Gasbarrini A (2005) Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 22:1157\u20131160","journal-title":"Aliment Pharmacol Ther"},{"key":"9401_CR2","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/j.1365-2036.2005.02493.x","volume":"2","author":"G Nucera","year":"2005","unstructured":"Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, Cammarota G, Tondi P, Pola P, Gasbarrini G, Gasbarrini A (2005) Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2:1391\u20131395","journal-title":"Aliment Pharmacol Ther"},{"key":"9401_CR3","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s10620-010-1276-4","volume":"55","author":"ED Shah","year":"2010","unstructured":"Shah ED, Basseri RJ, Chong K, Pimentel M (2010) Abnormal breath testing in IBS: a meta-analysis. Dig Dis Sci 55:2241\u20132249","journal-title":"Dig Dis Sci"},{"key":"9401_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/gut.2009.205476","volume":"60","author":"D Yu","year":"2011","unstructured":"Yu D, Cheeseman F, Vanner S (2011) Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut 60:334\u2013340","journal-title":"Gut"},{"key":"9401_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12876-016-0484-6","volume":"16","author":"EJ Giamarellos-Bourboulis","year":"2016","unstructured":"Giamarellos-Bourboulis EJ, Pyleris E, Barbatzas C, Pistiki A, Pimentel M (2016) Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent from proton pump inhibitor usage. BMC Gastroenterol 16:67","journal-title":"BMC Gastroenterol"},{"key":"9401_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s10620-012-2033-7","volume":"57","author":"E Pyleris","year":"2012","unstructured":"Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M (2012) The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 57:1321\u20131329","journal-title":"Dig Dis Sci"},{"key":"9401_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/MCG.0b013e318204593e","volume":"45","author":"CH Choi","year":"2011","unstructured":"Choi CH, Jo SY, Park HJ, Byeon JS, Myung SJ (2011) A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome. Effect on quality of life. J Clin Gastroenterol 45:679\u2013683","journal-title":"J Clin Gastroenterol"},{"key":"9401_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/MCG.0b013e31820ca4d6","volume":"45","author":"T Ringer-Kulka","year":"2011","unstructured":"Ringer-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringer Y (2011) Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders. A double-blind study. J Clin Gastroenterol 45:518\u2013525","journal-title":"J Clin Gastroenterol"},{"key":"9401_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MCG.0b013e31823712b1","volume":"46","author":"BK Cha","year":"2012","unstructured":"Cha BK, Jung SM, Choi CH, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG (2012) The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome. A randomized, double-blind placebo-controlled trial. J Clin Gastroenterol 46:220\u2013227","journal-title":"J Clin Gastroenterol"},{"key":"9401_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/jgh.12322","volume":"29","author":"JS Yoon","year":"2014","unstructured":"Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG (2014) Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol 29:52\u201359","journal-title":"J Gastroenterol Hepatol"},{"key":"9401_CR11","first-page":"9","volume":"35","author":"G Evaldson","year":"1982","unstructured":"Evaldson G, Heimdahl A, Kager L, Nord CE (1982) The normal human anaerobic microflora. Scand J Infect Dis Suppl 35:9\u201315","journal-title":"Scand J Infect Dis Suppl"},{"key":"9401_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/21505594.2016.1247140","volume":"8","author":"HE Hallen-Adams","year":"2017","unstructured":"Hallen-Adams HE, Suhr MJ (2017) Fungi in the healthy human gastrointestinal tract. Virulence 8:352\u2013358","journal-title":"Virulence"},{"key":"9401_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/ijcp.12128","volume":"67","author":"RH Roest De","year":"2013","unstructured":"De Roest RH, Dobbs BR, Chapman BA, Batman B, O\u2019Brien LA, Leeper JA, Hebblethwaite CR, Gearry RB (2013) The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract 67:895\u2013903","journal-title":"Int J Clin Pract"},{"key":"9401_CR14","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/ajg.2011.201","volume":"106","author":"DA Drossman","year":"2011","unstructured":"Drossman DA, Chang L, Bellamy N, Gallo-Torres HE, Lembo A, Mearin F, Norton NJ, Whorwell P (2011) Severity in irritable bowel syndrome: a Rome foundation working team report. Am J Gastroenterol 106:1749\u20131759","journal-title":"Am J Gastroenterol"},{"key":"9401_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis CY, Morris J, Whorwell PJ (1997) The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 11:395\u2013402","journal-title":"Aliment Pharmacol Ther"},{"key":"9401_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"TJ Louie","year":"2011","unstructured":"Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364:422\u2013431","journal-title":"N Engl J Med"},{"key":"9401_CR17","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thomson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480\u20131491","journal-title":"Gastroenterology"},{"key":"9401_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12876-016-0470-z","volume":"16","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Guo C, Mu D, Feng B, Zuo X, Li Y (2016) Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol 16:62","journal-title":"BMC Gastroenterol"},{"key":"9401_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/nmo.12544","volume":"27","author":"CH Choi","year":"2015","unstructured":"Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, Jee SR, Jeen YT, Choi MG, Choi SC, Huh KC, Park H (2015) Efficacy of a combination with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase III trial. Neurogastroenterol Motil 27:705\u2013716","journal-title":"Neurogastroenterol Motil"},{"key":"9401_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/apt.12787","volume":"40","author":"G Sisson","year":"2014","unstructured":"Sisson G, Ayis S, Sherwood RA, Bjarnason I (2014) Randomised clinical trial: a liquid multi-stain probiotic vs placebo in irritable bowel syndrome\u2014a 12 week double-blind study. Aliment Pharmacol Ther 40:51\u201362","journal-title":"Aliment Pharmacol Ther"},{"key":"9401_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/jam.13329","volume":"122","author":"K Nobutani","year":"2017","unstructured":"Nobutani K, Sawada D, Fujiwara S, Kuwano Y, Nishida K, Nakayama J, Kutsumi H, Azuma T, Rokutan K (2017) The effects of administration of Lactobacillus gasseri strain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome. J Appl Microbiol 122:212\u2013224","journal-title":"J Appl Microbiol"},{"key":"9401_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP (2011) Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 364:22\u201333","journal-title":"N Engl J Med"},{"key":"9401_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3109\/00365521.2015.1027261","volume":"50","author":"EJ Giamarellos-Bourboulis","year":"2015","unstructured":"Giamarellos-Bourboulis EJ, Tang J, Pyleris E, Pistiki A, Barbatzas C, Brown J, Lee CC, Harkins TT, Kim G, Weitsman S, Barlow GM, Funari VA, Pimentel M (2015) Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scand J Gastroenterol 50:1076\u20131087","journal-title":"Scand J Gastroenterol"},{"key":"9401_CR24","first-page":"1","volume":"200","author":"S Hempel","year":"2011","unstructured":"Hempel S, Newberry S, Ruelaz A, Wang Z, Miles JN, Suttorp MJ, Johnsen B, Shanman R, Slusser W, Fu N, Smith A, Roth B, Polak J, Motala A, Perry T, Shekelle PG (2011) Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess 200:1\u2013645","journal-title":"Evid Rep Technol Assess"}],"updated-by":[{"DOI":"10.1007\/s12602-018-9412-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000}}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-018-9401-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12602-018-9401-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-018-9401-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T13:13:47Z","timestamp":1567862027000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12602-018-9401-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9401"],"URL":"https:\/\/doi.org\/10.1007\/s12602-018-9401-3","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12602-018-9412-0","asserted-by":"object"}]},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"5 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article contained mistakes, and the authors would like to correct them. The correct details are given below.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None of the authors has any conflict of interest to declare in relation with this submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}